Search results
GOLD Report Now Available on AvoMD. The 2024 GOLD Report is now live on AvoMD! Get access to the latest, digitized, actionable recommendations at point-of-care. Try it now for FREE!
Chapter 1: Definition and Overview. Chapter 2: Diagnosis and Assessment. Chapter 3: Prevention and Management of COPD. Chapter 4: Management of Exacerbations. Chapter 5: COPD and Comorbidities. Chapter 6: COVID-19 and COPD. All table and figure numbers have been changed to consecutive figure numbers only.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report provides a review of the most current evidence for prevention of COPD as well as the assessment, diagnosis, and treatment of people with the disease.
GOLD 2024 continues to propose that a post-bronchodilator FEV 1 /FVC<0.7, in the appropriate clinical context, is mandatory to establish the diagnosis of COPD. 2 However, we also recognize that there is an ongoing, and not yet resolved, debate on two key aspects of this proposal.
4 gru 2023 · The 2024 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD) has been published.
1 cze 2024 · The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report provides a review of the most current evidence for prevention of COPD as well as the assessment, diagnosis, and treatment of people with the disease.
26 maj 2024 · This 2024 release is an update to the 2023 major revision. DEVELOPER: Global Initiative for Chronic Obstructive Lung Disease (GOLD) FUNDING SOURCE: GOLD. TARGET POPULATION: Adults with a diagnosis of or at risk for COPD
